Education and training

Professor

6304 Cancer Center

734-763-0325

dgbeer@umich.edu

EDUCATION AND TRAINING

1971-1975 Northeastern Illinois University, Chicago, IL., B.S. with Honors.

1980-1984 University of Colorado, Boulder, CO., Ph.D.

(Biochemical Pharmacology, Mentor: Alvin Malkinson, Ph.D.)

McArdle Laboratory for Cancer Research, Madison, WI.

(Molecular Oncology, Mentor: Henry Pitot, M.D., Ph.D.)
ACADEMIC APPOINTMENTS

1987-1991 Assistant Professor, Department of Pharmacology, Toxicology and Therapeutics, Center on Environmental and Occupational Health, University of Kansas Medical Center. Member,

Graduate Faculty.
1991 Assistant Professor, Departments of Surgery and Radiation Oncology, University of Michigan, Ann Arbor MI.
1991 Member, University of Michigan Comprehensive Cancer Center. Member of Cancer Genetics, Chemoprevention and Thoracic Oncology Programs
1991 Member, Cancer Biology Group, Department of Radiation Oncology.
1994 Associate Professor, Departments of Surgery and Radiation Oncology,

Director, Thoracic Research Laboratory, University of Michigan, Ann

Arbor MI.

2001. 
      Professor, Department of Surgery and Department of Radiation Oncology, Director, Thoracic Research Laboratory, University of Michigan, Ann Arbor MI.
      

2003 Co-Director, Cancer Genetics Program, University of Michigan Cancer Center

Cancer Center Support Grant

5 P30 CA46592-25

Period: 6/01/12 - 5/31/17

The core grant supports the senior leadership, programs and shared facilities of the Cancer Center. The Center provides the organizational framework to promote interdisciplinary research through the development of defined clinical, basic science and prevention programs in cancer research, and the development and support of shared resources.

Annual directs: $5,311,806
Identification and Characterization of Gene Fusions in Lung Adenocarcinoma

Principal Investigators: David G. Beer (22.8% effort), Arul Chinnaiyan

Agency: National Cancer Institute

Period: 4/01/2011 – 3/30/2016

This R01 proposal will identify new gene-fusions in lung cancer utilizing a newly developed bioinformatics approach combined with next-generation sequencing data.

$185,000 direct costs/yr.

Principal Investigators: Tom Wang, David G. Beer (22% effort), Eric Siebel

Period: 09/21/2011-8/31/2016

$830,151 annual direct costs

Co-Investigators: Guoan Chen, (25% effort)

3/01/12 – 2/29/17

$70,148 total annual costs MI

UMCCC-Endowed Research Fund

Period: 5/1/2011-

Principal Investigator: David G. Beer, Ph.D.

Co-Investigators: Andrew Chang, Jules Lin, Rishi Reddy, Lin Lin

$50,000 total costs.

Submitted:

Standardized NanoArray PCR for Gene Expression Profiling of

Lung Cancer

PA-11-096 PHS 2011-02 Omnibus Solicitation of the NIH, CDC, FDA and ACF for

Small Business Innovation Research Grant

Principle Investigators: Tony Godfrey, Tom Morrison, David G. Beer

$116,802 direct costs

Previous:

A Novel Computational Framework for Individualized Clinical Decision Making

Principal Investigator: Lan Guo, West Virginia University

(David G. Beer, Co-Investigator)(10% effort)

Agency: National Cancer Institute

Period: 9/15/08 – 9/14/11

$21,089 total costs

DOD NFGC

Period: 6/01/10 – 5/30/11

Principal Investigator: David G. Beer, Ph.D., 1% effort

Co-Investigators: Guoan Chen

$100,000 total costs.

UMCCC-Donald and Jo Anne Petersen Endowed Research Fund

Period: 11/1/2010-4/30/2012

Principal Investigator: David G. Beer, Ph.D.

Co-Investigators: Guoan Chen

$50,000 total costs.

Principal Investigator: Tom Wang (David G. Beer, Co-Investigator, 12% effort)

Agency: National Cancer Institute

U54 CA136429-01, Period: 10/01/08 – 8/30/11

$72,398 direct costs
Molecular Signatures of Lung Cancer

Principal Investigator: David Carbone, (David G. Beer, Ph.D., 15% effort)

Agency: National Cancer Institute

Type: 1U01 CA114771-06: Period: 6/1/2010 to 5/31/2011

$31,353 total costs
Molecular Studies of Esophageal Adenocarcinoma-Competitive Renewal

Principal Investigator: David G. Beer, Ph.D., (40% effort)

Agency: National Cancer Institute

Type: 2 R01 CA071606-09: Period: 06/01/2005 - 05/31/2010

$323,219 total direct costs/yr
Molecular Signatures of Lung Cancer

Principal Investigator: David Carbone, M.D., Ph.D., (David G. Beer, Ph.D., 15% effort)

Agency: National Cancer Institute

Type: 1U01 CA114771-01: Period: 7/01/05- 6/30/10

$57,577 total costs
Validation of Ubiquilin 1 in Lung Cancer

Principal Investigator: David G. Beer, Ph.D., 10% effort

Agency: National Cancer Institute/EDRN

Period: 8/1/08-7/31/09

$40,487 direct costs
Development and Validation of a qRT-PCR Classifier for Lung Cancer Prognosis

Principal Investigator: David G. Beer, Ph.D.

Agency: MICHR/CSTA

Period: 1/01/09 – 12/31/09

$75,000 direct costs only
Development and Validation of a qRT-PCR Classifier for Lung Cancer Prognosis

Principal Investigator: David G. Beer, Ph.D.

Agency: MIIE

Period: 5/15/09 – 3/15/11

$41,674 direct costs only
Humoral Signature of Lung Cancer

Principal Investigator: David G. Beer, Ph.D., 10% effort

Agency: National Cancer Institute/EDRN

Period: 9/01/05-8/31/07

$100,000 total direct costs
Molecular Studies of Esophageal Adenocarcinoma

Principal Investigator: David G. Beer, Ph.D., (40% effort)

Agency: National Cancer Institute

Type: CA 71606-01A1: Period: 7/01/00- 6/30/05

$1,125,000 total direct costs
Gene Expression Profiling of Squamous Cell Carcinomas of the Lung

David G. Beer, PI, 10% effort

Agency:Veridex Co.

Period: 5/01/04-1-30-05

Amount: $120,000 total costs.
Great Lakes-New England Clinical Epidemiology Center

Principal Investigator: D. Brenner, M.D.

D. Beer, Co-Investigator, 15% effort

Agency: National Cancer Institute

Type: U01 CA 86400: Period: 4/01/00-3/30/05

Amount: $1,112,132 total costs

Subproject: $49,520 direct costs
Lung Validation Study

Principal Investigator: David G. Beer, Ph.D., 10% effort

Agency: National Cancer Institute

Order No. 263-MQ-319735

Period: 9/25/03-9/25/04, $99,282 total costs

The goals are to investigate gene expression in human lung adenocarcinomas utilizing gene profiling technologies.

David G. Beer, Principal Investigator -Lung Project (20% effort)

Project Principal Investigator: Samir Hanash, M.D., Ph.D.

Agency: National Cancer Institute

Type: U19 CA 85953: Period: 10/1/99-9/30/04

$82,600/yr direct costs

Principal Investigator: S. M. Hanash, M.D., Ph.D., (David G. Beer, 5% effort)

Agency: National Cancer Institute

Type: U01 CA 84982: Period: 10/1/99-9/30/04

$530,000 total annual direct costs

University of Michigan Surgical Oncology Training Program

David G. Beer, PI (Temporary)

T32 CA009672-14 Period: 09/13/04-06/30/03

$272,833 total annual direct costs

Principal Investigator: David G. Beer, Ph.D., 10% effort replacing Dr. James Neel (deceased) as Principal Investigator in last year of the grant.

Agency: National Cancer Institute

CA 26803: Period 9-1-83- to 12/31/01

Amount: $1,116,724 total year 17.
Molecular Studies of Esophageal Adenocarcinoma

Principal Investigator: David G. Beer, Ph.D., 40% effort

Agency: National Cancer Institute

Type: CA 71606-01A1: Period: 6/01/97- 5/30/00,

$697,390 total direct costs
Evaluation of Selective Cox-2 inhibitors in Barrett’s Esophagus

Principal Investigator: David G. Beer, Ph.D.

Agency: Pharmacia

Period 7-1-00-6-30-01

$76,515 total costs
National Institutes of Health/NCI, 12/01/96-11/30-98

Phase II Clinical Trial of Difluoromethylornithine (DFMO) in Barrett's Esophagus,

15% effort.

NO1-CN-55107-32 (D. Brenner, PI)

Amount: $1,800,000 total costs.

American Cancer Society, 1996-1999, PI.

$300,000 total costs.
Altered Gene Expression During Mouse Lung Carcinogenesis.

National Institutes of Health, 1990-1996, RO1-CA-46433, PI.

$246,281.

Role of AP-1 in K-ras Mediated Lung Cell Transformation

American Cancer Society, 1993-1995, RO1-CN35D, PI.

$150,000.

Role of AP-1 in K-ras Mediated Lung Cell Transformation.

American Cancer Society, 1993, RO1-CN35C,

PI. $34,000.

Renewal: Regulation of Mouse Lung Tumor Susceptibility and Development

American Cancer Society, 1991-1992, RO1-CN35B, PI.

$106,636.
Regulation of Mouse Lung Tumor Susceptibility and Development.

American Cancer Society, 1989-1990, RO1-CN35A, PI.

$107,126.

Glucocorticoid Regulation of Normal and Neoplastic Lung Development, Pharmaceutical Manufacturers Association Foundation, 1988-1989, PI.

$20,000.
Genetics of Pulmonary Tumor Susceptibility

Speas Foundation, 1988, PI.

$20,000.

Biomedical Research Support Grant (NIH), 1987, PI.

Kansas University of Medical Center, $15,000.
National Institutes of Health, 1984-1986, CA-07652.

McArdle Laboratory, University of Wisconsin.

Individual NRSA Postdoctoral Fellowship, Experimental Pathology.

HONORS AND AWARDS

1981-1983 Elected University of Colorado, School of Pharmacy Graduate Student Representative and Graduate Committee Member.

1982 Rho Chi Honor Society.

1983 University of Colorado, Graduate School Foundation Fund Award.

1983 American Society for Pharmacology and Experimental Therapeutic Graduate Student Travel Award.

1984. 
      University of Colorado, Harold Heim Research Award.
      

2002 UM Medical School TAMS Award

The Society for Developmental Biology, 1988 - 2001.

American Association for Cancer Research (AACR), 1988 - present.

American Association for the Advancement of Science (AAAS), 1984 - present.

Society for Experimental Biology and Medicine, 1993- 2001.

International Association for the Study of Lung Cancer (IASLC)-2005-present

1987-1991 Study Section Member, American Cancer Society, Kansas Chapter.

1986 Ad Hoc Grant Reviewer, National Science Foundation.

1987 American Cancer Society Priority Grant Reviewer.

1991-1992 Ad Hoc Study Section Member, Carcinogenesis and Nutrition, American Cancer Society.

1993-2001 Department of Surgery Research Advisory Committee.

1998, 1999 Grant Reviewer for Ohio Cancer Research Associates.

1999 Merit Grant Reviewer for Department of Veteran Affairs.

2000 Grant Reviewer for Northwest Cancer Research Fund, Liverpool, UK.

2000, 2001 Grant Reviewer for Molecular Genetics 2 Study Section for U.S. Army Breast Cancer Program, DOD.

2000, 2001 Merit Grant Reviewer for Department of Veteran Affairs

2001. 
      Grant Reviewer, Dutch Cancer Society.
      

2002-2007 ACS Study Section Member, Carcinogenesis (CNE)

2002 Member, NCI site visit team.

2001. 
      NCI Esophageal Study Group Member
      
2002. 
      Member, NCI site visit team.
      

Windber, PA.

2003 Study Section member, California-TRDRP

2003 Grant Reviewer, Cancer Research UK

2004 Grant Reviewer Danish Cancer Society 2004 Grant Reviewer Italian Association for Cancer Research (AIRC)
2004 Study Section Member, California-TRDRP

2004 Grant Reviewer, Nova Scotia Health Research Foundation

2005 Study Section member, California-TRDRP

2005 Grant Reviewer, NCI Special Emphasis Panel

2005 Grant Reviewer, The Prince Charles Hospital Foundation, Australia

2005 Grant Reviewer, NCI Molecular Oncogenesis study section

2006 Study Section Co-Chair, Carcinogenesis, Nutrition and the Environment, American Cancer Society.

2006 Grant Reviewer, Cancer Research UK

2006 Grant Reviewer, Swiss Cancer League

2006 Site Visit Member, NCI, Laboratory for Comparative Carcinogenesis

2006 Grant Reviewer, Kentucky Lung Cancer Research Program

2006 Member, UMCCC Cancer Research Committee

2007 Chair, Carcinogenesis, Nutrition and the Environment, American Cancer Society.

2007 Grant Reviewer, The Cancer Research Society, Health Canada

2007 Grant Reviewer, Cancer Research UK

2007 Grant Reviewer, California TRDRP

2008 Grant Reviewer ACS, Carcinogenesis (CNE)

2008 Grant Reviewer Cancer UK

2008 Grant Reviewer, Kentucky Lung Cancer Research Program

2008 Grant Reviewer, FAMRI Lung Cancer Program

2009 Grant Reviewer, California TRDRP

2009 Site Visit Member, NCI-EDRN, UT-Southwestern Medical Center

2009 Grant Reviewer, Kentucky Lung Cancer Research Program

2009 Grant Reviewer, Cancer UK

2009 Grant Reviewer, Dutch Cancer Society

2009 Grant Reviewer, NCI-Challenge Grants

2010 Grant Reviewer, California TRDRP

2011 Grant Reviewer, California TRDRP

2011 Grant Reviewer, The Prince Charles Hospital Foundation, Queensland

2011 Grant Reviewer, NCI ad hoc member Cancer Genetics study section

2011 WCLC2011 Scientific Committee

2011- Department of Surgery, Promotions Research Track Committee

2010- Admissions Committee PIBS/Cancer Biology graduate program

2012 Grant Reviewer, Kentucky Lung Cancer Research Program

2012 Grant Reviewer and Chair, California TRDRP

2011- GI SPORE Senior Scientific Advisory Board

2012 University of Minnesota Cancer Center, Scientific Advisory Board

2012- Director, UMCCC Cancer Biology Summer Internship program

2013 University of Minnesota Cancer Center, Scientific Advisory Board

Editorial Boards: 2001-Associate Editor, Clinical Cancer Research

2003-2004 Associate Editor, 2005- Editorial Board, Transactions of the Integrated Biomedical Informatics and Enabling Technologies Symposium (TIBETS)

2003- Associate Editor, International Journal of Oncology

2005- Associate Editor, Cancer Research

2006-Editorial Board, Featured Cover for February International Journal of Oncology

2007-Editorial Board, Translational Oncology

2010- Associate Editor, Carcinogenesis

2010- Associate Editor, Journal of Thoracic Oncology

2011-Editorial Board, Translational Research

New England Journal of Medicine

PLOS

Nature Medicine

Molecular Medicine

Journal of the National Cancer Institute

Gastroenterology

Journal of Clinical Oncology

International Journal of Cancer

Proceedings of the National Academy of Science

Neoplasia

European Journal of Cancer

Molecular and Cellular Proteomics

1984, NCI-Sponsored Workshop on "Histopathobiology of Neoplasia", Aspen, CO.

1986, Workshop on "In Situ Hybridization", Tufts University, Boston, MA.

1988, NCI Sponsored two-week workshop on: "Somatic Cell and Molecular Genetics", Eleanor Roosevelt Cancer Institute, Denver, CO.

1991 Jerome Seid, M.D., Hematology-Oncology Resident.

1991-1992 Mazin Al-Kasspooles, Medical Student.

1992-1994 Philip Bongiorno, M.D., General Surgery Resident.

1992 Richard Whyte, M.D.,Thoracic Surgery Resident.

1992-1993 Eric Lesser, Undergraduate Biology Student.

1993-1994 Lee Huo, Undergraduate Summer Fellowship Student.

1993-1994 William Rachwal, M.D., General Surgery Resident.

1993-1994 Mark Iannettoni, M.D., Thoracic Surgery Resident.

1993 David Webster, Medical Student.

1995 Bruce Leuchter. premedical Student.

1995 Stan Lee, Medical Student.

1996 Ted Skolaris, Kevin Schafer, undergraduate students.

1996-1998 Steve Hughes, M.D., General Surgery Resident.

1996-1997 Oliver Soldes, M.D., General Surgery Resident.

1996 Carrie Sutton, Justin Moy, undergraduate students.

1997 Keith Compton, Iran Thompson, Medical Students

1997-1998 David Corteville, Marcy Coash, UROP students

1998-2000 Sanjeev Aggarwal, M.D., General Surgery Resident.

1998- Lin Lin, M.D., Ph.D, Post-doctoral Fellow.

1998-1999 Neeju Ravikant, M.D., Ph.D, Post-doctoral Fellow.

1999 Puja Singh, Hari Kumar, undergraduate students.

2000-2001 Hideo Umezu, M.D., Visiting Research Scholar, Japan

2000 Theodore Lin, Medical student summer grant project

2000-2001 Hari Kumar, Honors thesis student research advisor

2001-2002 Chris Moran, M.D. General Surgery Resident

2001 Michael Prescott, Medical student summer grant project

2002 Andrew Heaford, Medical student summer grant project

2001. 
      Susie Lee, Student of Public Health, summer project.
      

2002-2004 Jules Lin, General Surgery Resident,

2002. 
      2006 Duna Raoof, undergraduate student.
      

2005. 
      Anika Kumar, engineering student
      

2007-2009 Chris Seder, Wibi Hartojo, General Surgery Residents

2007-2009 Tasneem Kausar, graduate student.

2010- Jiwon Lee, graduate student.

2010- Igor Rybkin, M.D, PhD, Medical Oncology Resident

2010- Ernest Nadal Alforja, M.D., Medical Oncology Resident

2011- Alyssa Cates, graduate student rotation

2012- Carla Ramos, graduate student rotation

2012- Daysha Ferrer Torres, Graduate student rotation

2012- Katie Speilbauer, Cancer Research Summer Intern

2012- Ali Bazzi, Medical Student SBRP summer program

2013- Nancy Pinnell, graduate student rotation

2003 Spencer Huang, Biostatistics

2006 Chad Creighton, Bioinformatics Preliminary Exam Committee, Ph.D. Thesis Committee

2008 Sinjan Wang, Biostatistics

2008 Dhruv Sud, Bioengineering

2009-2012 John R. Prensner, M.D., Ph.D. Dissertation committee, MSTP program

2010-2012 Gwyneth Halstead-Nussloch, Cancer Biology

2011- Heather Waline, Preliminary exam committee, Dissertation committee

2011- Mentor T32 Oncology Training grant

2011- Mentor T32 Surgical Oncology Training grant

2011- Advisory Committee T32 Biostatistics Training grant

2012- Brittany Bowman, Dissertation committee, Cancer Biology

2013- Anirban Sahu, Dissertation committee

2013- Brendan Veeneman, Dissertation committee

2013- Allison Fullenkamp, Dissertation committee, Cancer Biology

2013- Melanie Krook, Dissertation committee, Cancer Biology

2013- Linbo Zhao, Dissertation committee, Cancer Biology

Presentations:

1991-present. Radiation Oncology/Cancer Biology Seminars.

1991-present. Thoracic Surgery Laboratory Seminars.

May 1992, Moses Gunn Surgery Research Conference,“ EGFR/ErbB2 Gene Alterations in Human Esophageal Adenocarcinomas”.

Sept. 25, 1992, 3rd Annual Cancer Research Conference, American Cancer Society, “Analysis of EGFR and ErbB2 Genes in Human Esophageal Adenocarcinomas and Barrett’s Esophagus”.

November, 1992. Department of Surgery Seminar, "New Insights into Human Esophageal Cancer".

February, 1993. Cancer Center, Carcinogenesis Program Seminar.

May, 1993, Moses Gunn Surgery Research Conference, "Intestinal Differentiation and p53 Gene Alterations in Barrett's Esophagus and Adenocarcinoma".

May 1994, Moses Gunn Surgery Research Conference, laboratory presented two posters and one oral presentation.

Nov. 18, 1994, 4th Annual Cancer Research Conference, American Cancer Society, laboratory presented two posters.

January 27, 1995. Department of Surgery Seminar, "Short-term organ culture of Barrett's mucosa-A new model to study epithelial regulation".

May 1995, Moses Gunn Surgery Research Conference, laboratory presented one oral presentation.

October 28, 1994. University of Michigan Cancer Center, Chemoprevention Group, "Barrett's Metaplasia".

November 16, 1995, Department of Internal Medicine, Seminar.

Nov. 17, 1995, Annual Cancer Research Conference, American Cancer Society, Michigan State University, presented poster.

January 17, 1996, Department of Pharmacology, Seminar.

May 1996, Moses Gunn Surgery Research Conference, oral presentation.

October 3, 1996, Department of Surgery Grand Rounds.

October 23, 1996, Department of Anatomy and Cell Biology, Seminar.

May 1997, Moses Gunn Surgery Research Conference, laboratory presented one oral presentation and one poster.

May 1998, Moses Gunn Surgery Research Conference, laboratory presented one oral presentation and two posters.

May 1999, Moses Gunn Surgery Research Conference, laboratory presented one oral presentation and one poster.

April 2000, Moses Gunn Surgery Research Conference, laboratory presented two oral presentations.

May 2001, Moses Gunn Surgery Research Conference, laboratory presented one oral presentation and two posters.

September 4, 2001, Thoracic Oncology Research Conference Seminar

May 2002, Moses Gunn Surgery Research Conference, laboratory presented one oral presentation and two posters.

November 4, 2002, Thoracic Oncology Research Conference Seminar

May 2003, Moses Gunn Surgery Research Conference, laboratory presented one oral presentation and four posters. Lin Lin received outstanding poster award.

May 2004, Moses Gunn Surgery Research Conference, laboratory presented two oral presentation and three posters. Jules Lin received “Young Investigator” award and Charles Miller outstanding poster award.

May 2005, Moses Gunn Surgery Research Conference

May 2006, Moses Gunn Surgery Research Conference

Lectures:

December 11, 1993, Department of Surgery, "Tumor Biology" given to General Surgery Residents.

December 3, 1994, Department of Surgery, "Tumor Biology" given to General Surgery residents.

December 10, 1994. Thoracic Surgery Didactic Series, " Molecular Biology of Thoracic Neoplasms".

December 1995, Department of Surgery, "Tumor Biology" given to General Surgery residents.

February 1, 15, 22 and March 21, 1996: Lectures on Molecular Biological Techniques given to General Surgery Residents.

September 17, 1996: Micro/Immuno/Path 553. Carcinogenesis.

September 21, 1997: Micro/Immuno/Path 553. Carcinogenesis.

September 15, 1998: Micro/Immuno/Path 553. Carcinogenesis.

September 16, 1999: Micro/Immuno/Path 553. Carcinogenesis.

September 14, 2000:Micro/Immuno/Path 553. Carcinogenesis.

September 14, 2000:Organogenesis Graduate Program. “Organogenesis and Carcinogenesis of the Esophagus”

November 18, 2000: Molecular genetics of lung and esophageal cancer, Thoracic Surgery Didactic Conference.

September 18, 2001:Micro/Immuno/Path 553. Carcinogenesis.

December 6, 2001: Micro/Immuno/Path 553. Molecular Profiling.

February 12, 2002: K30 Translational Research Course: Application of Gene and Protein Profiling to the Medical Sciences

September 12, 2002:Micro/Immuno/Path 553. Chemical Carcinogenesis.

December 5, 2002: Micro/Immuno/Path 553. Molecular Profiling.

February 7, 2003: Biostatistics: Gene Expression Techniques

February 21, 2003: Biostatistics: Gene Expression Techniques

September 8, 2003:Micro/Immuno/Path 553. Chemical Carcinogenesis.

September 14, 2004:Micro/Immuno/Path 553. Chemical Carcinogenesis.

November 13, 2004: Molecular genetics of esophageal cancer, Thoracic Surgery Didactic Conference.

September 13, 2005:Micro/Immuno/Path 553. Chemical Carcinogenesis.

September 12, 2006:Micro/Immuno/Path 553. Chemical Carcinogenesis.

January 29, 2007: Thoracic Oncology Update, Cancer Center Grand Rounds

February 7, 2007, Esophageal Cancer Genetics lecture, Thoracic Surgery

February 14, 2007, Hematology Oncology Fellows lecture

September 10, 2007:Micro/Immuno/Path 553. Chemical Carcinogenesis.

September 11, 2008:Micro/Immuno/Path 553. Chemical Carcinogenesis.

December 10, 2008:Hematology Oncology Fellows lecture.

September 22, 2009:Micro/Immuno/Path 553. Chemical Carcinogenesis.

January 26, 2010, PIBS 507, Translational Research

September 21, 2010:Micro/Immuno/Path 553. Chemical Carcinogenesis.

September 13, 2011:Micro/Immuno/Path 553. Chemical Carcinogenesis.

October 13, 2011, Society of Biology Students: Lung Cancer.

September 11, 2012:Micro/Immuno/Path 553. Chemical Carcinogenesis.